🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Honoured to review updates in MDS and AML. Menin mania, long-term outcomes with 1L luspatercept, imetelstat, and so much more! MD Anderson Cancer Center #MDSsm #AMLsm

OCE Publication: Advancing Drug Development in Myelodysplastic Syndromes - collaboration between FDA, NCI, academia, and other stakeholders following our public workshop on advancing drug development in MDS. Blood Advances ashpublications.org/bloodadvances/…

💯

Plasma Olink Proteomics study of large vessel vasculitis spectrum revealed •Highly similar proteomic signatures in Takayasu & GCA •↑ Innate immune activation, and ↑ stromal remodeling Results have implications for biomarker and drug design In A&R doi.org/10.1002/art.43…

Great discussion underway, join!

This has promise to change surgery. We haven’t had a new class of painkillers for acute pain for decades. And 15,000 people died of prescription opioid overdoses in 2022. But will be interested in hearing from anyone with real world experience. bostonglobe.com/2025/01/30/bus…

More on immune dysfunction in myeloid malignances simona colla shares 👌🏼 data on irreversible dysfunction of clonal NK cells in MDS (early as CCUS), in part due to 🚫 NK synapse formation w/ loss of TET2 & DNMT3A #i4MDS MD Anderson Cancer Center Valeria Santini Shahram Kordasti #mdssm

CONGRESS | #Tandem25 | PRESENTATION Uday Popat, MD Anderson Cancer Center, presents results from a phase II trial evaluating myeloablative fractionated busulfan, fludarabine, cladribine, thiotepa and venetoclax (Cladillac) conditioning regimen for allo-HSCT in 49 patients with very

Early attainment of undetectable MRD by MFC is independently associated w/ improved RFS in newly diagnosed #AML. Intermediate risk pts who attain undetectable MRD should still undergo consolidative allo-SCT. MD Anderson Cancer Center #Leukemia ASH ashpublications.org/bloodadvances/…

👉👉👉MD Education MPN, CHIP/CCUS & MDS faculty all coming together to discuss new ideas ! #MPNSM #leusm ||| 🙌 💡 Ruben A. Mesa, MD Naveen Pemmaraju, MD | Heme Reports MPNCo&D Congress Aditi Pemmaraju, J.D. Sanam Loghavi, MD صنم لغوی 🔬🧬 Hannah Goulart Zhuoer (Zoey) Xie, MD, MSCR Yazan Madanat, MD Mike Fradley, MD Elf Lab 🇺🇦🏳️‍🌈🏳️‍⚧️⚧️👊🏾👊🏽🌈🟧

Fantastic study & findings from Ashwin Kishtagari, MD & VUMC collaborators like Alex Bick ! Hopefully the start of many more studies to come.

Great post by David Steensma, MD highlighting the difficulties of treating neoplastic conditions. When a trial is “negative” it’s not the fault of the drug, the trial design, the investigators, or patients. Some cancers and pre cancers are just inherently hard to tackle:

Oncostatin M receptor is a single marker with strong predictive power of patient outcome, induction therapy response, and early mortality. ow.ly/a8Jq50WcXTJ #myeloidneoplasia

“We’re starting to see that patients treated with luspatercept have significantly longer survival compared to those treated with epoetin alfa,” G Garcia-Manero said. Bristol Myers Squibb sohoinsider.com/meetings-confe…

FDA drops REMS requirement for 6 CAR-T therapies sohoinsider.com/leukemia/fda-r…

Very very cool! #vexas

👉👉👉Delighted to share our group’s new paper 📣 Nature Genetics led by .Koichi Takahashi and team MD Anderson Cancer Center 👏 👏 👏 #leusm #endcancer | Naval Daver, M.D. Naveen Pemmaraju, MD Nitin Jain Robert Z. Orlowski Muzaffar Qazilbash Rashmi Kanagal-Shamanna, MD Dr. Elizabeth Shpall Peggy Goodell || nature.com/articles/s4158… ||

👉👉👉Delighted to share our new collaborative article in Leukemia Journal led by 🚨 Mrinal Patnaik & Guillermo Montalban-Bravo & Eric Padron MD | Sanam Loghavi, MD صنم لغوی 🔬🧬 Rashmi Kanagal-Shamanna, MD Naveen Pemmaraju, MD Rami komrokji Naseema Gangat nature.com/articles/s4137… | #leusm #TET2

Primary impact of clonal hematopoiesis on the outcomes of BCMA CAR-T in MM: prolonged transfusion-dependent cytopenias #mmsm #bmtsm Noopur Raje Blood Journals Portfolio ashpublications.org/bloodadvances/…

👉Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation | ⁦Nature Genetics⁩ .⁦Koichi Takahashi⁩ #leusm #endcancer nature.com/articles/s4158…